Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YDR059C | UBC5 | SGDID:S000002466 | hus5 ubc9 SPAC30D11.13 |
SUMO-conjugating enzyme ubc9 (EC 2.3.2.-) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein hus5) (Ubiquitin-conjugating enzyme E2-18 kDa) |
2.3.2.- | Schizosaccharomyces pombe | 3rcz_b | P40984 | 100.00 | 7.00E-36 | 4.50E-40 | 187.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2I UBC9 UBCE9 |
SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18) |
2.3.2.- | Homo sapiens | Cockayne Syndrome |
4y1l_a | P63279 | ENSG00000103275 | UBE2I | 100.00 | 2.00E-35 | 1.30E-39 | 184.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | Ubiquitin-conjugating enzyme |
Ubiquitin-conjugating enzyme |
Naegleria fowleri | 5v0r_a | A0A1W2VMZ9 | 99.90 | 2.30E-33 | 1.50E-37 | 176.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR059C | UBC5 | SGDID:S000002466 | UBE2G2 UBC7 |
Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2) |
2.3.2.23 | Homo sapiens | Machado-Joseph Disease,N Syndrome |
3h8k_a | P60604 | ENSG00000184787 | UBE2G2 | 100.00 | 2.50E-34 | 1.60E-38 | 180.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2U |
Ubiquitin-conjugating enzyme E2 U (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U) |
2.3.2.23 | Homo sapiens | Hypertropia,Brachydactyly, Type E2,Riddle Syndrome |
1yrv_a | Q5VVX9 | ENSG00000177414 | UBE2U | 99.90 | 2.00E-33 | 1.30E-37 | 176.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | PEX4 PAS2 UBC10 YGR133W |
Ubiquitin-conjugating enzyme E2-21 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme PEX4) (Peroxin-4) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) |
2.3.2.23 | Saccharomyces cerevisiae | 2y9m_a | P29340 | 99.90 | 1.30E-31 | 8.10E-36 | 169.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2D2 PUBC1 UBC4 UBC5B UBCH4 UBCH5B |
Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1) |
2.3.2.23,2.3.2.24, | Homo sapiens | Retinitis Pigmentosa,Peroxisome Biogenesis Disorder 1b,Machado-Joseph Disease,Parkinson Disease, Late-Onset,Gordon Holmes Syndrome |
2esk_a | P62837 | ENSG00000131508 | UBE2D2 | 100.00 | 7.60E-35 | 4.80E-39 | 179.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | BIRC6 KIAA1289 |
Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) |
2.3.2.27 | Homo sapiens | Brain Cancer,Schizophrenia,Autism Spectrum Disorder,Autism |
3ceg_a | Q9NR09 | ENSG00000115760 | BIRC6 | 99.90 | 1.60E-30 | 1.00E-34 | 176.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBC13 YDR092W YD6652.04 |
Ubiquitin-conjugating enzyme E2 13 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 13) (Ubiquitin carrier protein 13) (Ubiquitin-protein ligase 13) |
2.3.2.23 | Saccharomyces cerevisiae | 5ojw_a | P52490 | 100.00 | 4.30E-35 | 2.80E-39 | 181.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | Tc00.1047053506635.90 |
Tc00.1047053506635.90 |
Trypanosoma cruzi | 4ds2_a | Q4DIQ3 | 99.90 | 6.00E-30 | 3.80E-34 | 160.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR059C | UBC5 | SGDID:S000002466 | RAD6 UBC2 YGL058W |
Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Radiation sensitivity protein 6) (Ubiquitin carrier protein UBC2) (Ubiquitin-protein ligase UBC2) |
2.3.2.23 | Saccharomyces cerevisiae | 4r62_a | P06104 | 100.00 | 7.60E-36 | 4.90E-40 | 188.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2G1 UBE2G |
Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] |
2.3.2.23 | Homo sapiens | Leukoencephalopathy With Vanishing White Matter |
2awf_a | P62253 | ENSG00000132388 | UBE2G1 | 99.90 | 1.40E-32 | 8.70E-37 | 173.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2Z HOYS7 |
Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) |
2.3.2.23 | Homo sapiens | Type 1 Diabetes Mellitus 19 |
5a4p_a | Q9H832 | ENSG00000159202 | UBE2Z | 99.90 | 1.00E-31 | 6.50E-36 | 183.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2D1 SFT UBC5A UBCH5 UBCH5A |
Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Stimulator of Fe transport) (SFT) (UBC4/5 homolog) (UbcH5) (Ubiquitin carrier protein D1) (Ubiquitin-conjugating enzyme E2(17)KB 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase D1) |
2.3.2.23,2.3.2.24, | Homo sapiens | Shigellosis,Charcot-Marie-Tooth Disease,Gordon Holmes Syndrome |
2yho_b | P51668 | ENSG00000072401 | UBE2D1 | 100.00 | 1.40E-35 | 9.30E-40 | 183.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2S E2EPF OK/SW-cl.73 |
Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S) |
2.3.2.23 | Homo sapiens | Uterine Adnexa Cancer,Angelman Syndrome,Parkinson Disease, Late-Onset,Mental Retardation, Autosomal Dominant 20,Liddle Syndrome 1,Cortical Dysplasia, Complex, With Other Brain Malformations 6,Charcot-Marie-Tooth Disease, Axonal, Type 2p |
1zdn_b | Q16763 | ENSG00000108106 | UBE2S | 100.00 | 7.10E-34 | 4.60E-38 | 177.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2L6 UBCH8 |
Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6) |
2.3.2.23 | Homo sapiens | 1wzv_b | O14933 | ENSG00000156587 | UBE2L6 | 99.90 | 9.00E-33 | 5.80E-37 | 171.60 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR059C | UBC5 | SGDID:S000002466 | UBE2K HIP2 LIG |
Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase) |
2.3.2.23 | Homo sapiens | Uterine Adnexa Cancer,Angelman Syndrome,Mental Retardation, Autosomal Dominant 20,Disease Of Mental Health,Liddle Syndrome 1,Cortical Dysplasia, Complex, With Other Brain Malformations 6,Charcot-Marie-Tooth Disease, Axonal, Type 2p,Juvenile-Onset Parkinson'S Disease,Lung Cancer |
3k9o_a | P61086 | ENSG00000078140 | UBE2K | 99.90 | 6.40E-33 | 4.10E-37 | 178.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | PF3D7_0527100 |
PF3D7_0527100 |
6.3.2.19 | Plasmodium falciparum | 2r0j_a | Q8I3J4 | 100.00 | 4.80E-35 | 3.10E-39 | 180.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | CDC34 UBCH3 UBE2R1 |
Ubiquitin-conjugating enzyme E2 R1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme R1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1) |
2.3.2.23,2.3.2.24, | Homo sapiens | Neuronal Ceroid Lipofuscinosis,Ceroid Lipofuscinosis, Neuronal, 2,Ceroid Lipofuscinosis, Neuronal, 1 |
3rz3_d | P49427 | ENSG00000099804 | CDC34 | 99.90 | 4.20E-33 | 2.70E-37 | 177.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2L3 UBCE7 UBCH7 |
Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3) |
2.3.2.23 | Homo sapiens | Angelman Syndrome,Machado-Joseph Disease,Papilloma,Parkinson Disease, Late-Onset,Glycogen Storage Disease Iv,Chromosome 22q11.2 Deletion Syndrome, Distal,Keloid Formation,Systemic Lupus Erythematosus,Celiac Disease 1,Gordon Holmes Syndrome |
4q5e_c | P68036 | ENSG00000185651 | UBE2L3 | 99.90 | 1.80E-33 | 1.20E-37 | 174.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | EHI_070750 EHI_083560 |
EHI_070750 EHI_083560 |
Entamoeba histolytica | 4gpr_a | C4M5T2 | 99.90 | 1.10E-33 | 7.10E-38 | 175.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR059C | UBC5 | SGDID:S000002466 | UBE2M UBC12 |
NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M) |
2.3.2.34 | Homo sapiens | Familial Hypertension |
1y8x_a | P61081 | ENSG00000130725 | UBE2M | 99.90 | 1.20E-32 | 7.90E-37 | 171.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | PY01609 |
PY01609 |
2.3.2.23 | Plasmodium yoelii | 2pwq_a | Q7RP52 | 100.00 | 3.50E-34 | 2.20E-38 | 186.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | let-70 ubc-2 M7.1 |
Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2) |
2.3.2.23 | Caenorhabditis elegans | 1z2u_a | P35129 | 100.00 | 5.40E-36 | 3.50E-40 | 185.30 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2B RAD6B |
Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B) (HR6B) (hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B) |
2.3.2.23 | Homo sapiens | Male Infertility,Vas Deferens, Congenital Bilateral Aplasia Of,Halothane Hepatitis |
1jas_a | P63146 | ENSG00000119048 | UBE2B | 100.00 | 6.50E-34 | 4.20E-38 | 176.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | ubc15 SPBC1105.09 |
Ubiquitin-conjugating enzyme E2 15 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 15) (Ubiquitin carrier protein 15) (Ubiquitin-protein ligase 15) |
2.3.2.23 | Schizosaccharomyces pombe | 5knl_c | Q9Y818 | 99.90 | 3.60E-32 | 2.30E-36 | 171.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBC12 YLR306W L2142.3 |
NEDD8-conjugating enzyme UBC12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12) |
2.3.2.34 | Saccharomyces cerevisiae | 3o2u_a | P52491 | 99.90 | 1.50E-32 | 9.80E-37 | 175.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | LMJF_32_0700 |
LMJF_32_0700 |
6.3.2.19 | Leishmania major | 1yf9_a | Q4Q5L3 | 99.90 | 9.30E-31 | 6.00E-35 | 164.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBC1 YDR177W YD9395.10 |
Ubiquitin-conjugating enzyme E2 1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 1) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-protein ligase) |
2.3.2.23 | Saccharomyces cerevisiae | 1fxt_a | P21734 | 99.90 | 3.80E-33 | 2.40E-37 | 172.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2H |
Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) |
2.3.2.23,2.3.2.24, | Homo sapiens | Frontometaphyseal Dysplasia |
2z5d_a | P62256 | ENSG00000186591 | UBE2H | 99.90 | 2.10E-30 | 1.40E-34 | 164.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2T HSPC150 PIG50 |
Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T) |
2.3.2.23 | Homo sapiens | Fanconi Anemia, Complementation Group V,Fanconi Anemia, Complementation Group R,Fanconi Anemia, Complementation Group U,Fanconi Anemia, Complementation Group Q,Fanconi Anemia, Complementation Group O,Fanconi Anemia, Complementation Group C,Fanconi Anemia, Complementation Group D2,Fanconi Anemia, Complementation Group A,Fanconi Anemia, Complementation Group N,Fanconi Anemia, Complementation Group L,Fanconi Anemia, Complementation Group D1,Fanconi Anemia, Complementation Group T |
5ojj_e | Q9NPD8 | ENSG00000077152 | UBE2T | 100.00 | 1.80E-34 | 1.20E-38 | 179.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2E1 UBCH6 |
Ubiquitin-conjugating enzyme E2 E1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme E1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme E1) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1) |
2.3.2.23,2.3.2.24, | Homo sapiens | Spinocerebellar Ataxia 1 |
5lbn_a | P51965 | ENSG00000170142 | UBE2E1 | 100.00 | 6.90E-36 | 4.40E-40 | 186.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | SCE1 AHUS5 EMB1637 At3g57870 T10K17.80 |
SUMO-conjugating enzyme SCE1 (EC 2.3.2.-) (Protein EMBRYO DEFECTIVE 1637) (Protein hus5 homolog) (SUMO-conjugating enzyme 1) (AtSCE1) |
2.3.2.- | Arabidopsis thaliana | 6gv3_a | Q42551 | 100.00 | 1.30E-34 | 8.40E-39 | 183.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | PEX4 |
Ubiquitin-conjugating enzyme E2-21 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme PEX4) (Peroxin-4) (Ubiquitin carrier protein) (Ubiquitin-protein ligase) |
2.3.2.23 | Pichia angusta | 5nl8_a | O60015 | 99.90 | 2.50E-33 | 1.60E-37 | 178.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2N BLU |
Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N) |
2.3.2.23 | Homo sapiens | Shigellosis,Machado-Joseph Disease,Charcot-Marie-Tooth Disease,Parkinson Disease, Late-Onset,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Riddle Syndrome |
3w31_b | P61088 | ENSG00000177889 | UBE2N | 100.00 | 1.20E-34 | 7.50E-39 | 180.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2F NCE2 |
NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F) |
2.3.2.32 | Homo sapiens | Brachydactyly, Type E2 |
2edi_a | Q969M7 | ENSG00000184182 | UBE2F | 99.90 | 1.20E-32 | 7.80E-37 | 173.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBC9 YDL064W |
SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (Ubiquitin carrier protein 9) (Ubiquitin-conjugating enzyme E2-18 kDa) (Ubiquitin-protein ligase) |
2.3.2.- | Saccharomyces cerevisiae | 2gjd_d | P50623 | 100.00 | 1.20E-34 | 7.40E-39 | 180.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBC7 QRI8 YMR022W YM9711.12 |
Ubiquitin-conjugating enzyme E2 7 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 7) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-18 kDa) (Ubiquitin-protein ligase) |
2.3.2.23 | Saccharomyces cerevisiae | 2ucz_a | Q02159 | 100.00 | 1.60E-34 | 1.10E-38 | 181.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | UBE2C UBCH10 |
Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C) |
2.3.2.23,2.3.2.24, | Homo sapiens | Methotrexate-Associated Lymphoproliferation,Gastric Cancer,Complement Component 7 Deficiency |
4yii_u | O00762 | ENSG00000175063 | UBE2C | 99.90 | 1.90E-32 | 1.20E-36 | 170.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR059C | UBC5 | SGDID:S000002466 | UBE2K HIP2 |
Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase) |
2.3.2.23 | Bos taurus | 2bep_a | P61085 | 99.90 | 6.80E-33 | 4.30E-37 | 172.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR059C | UBC5 | SGDID:S000002466 | PF3D7_0915100 |
PF3D7_0915100 |
6.3.2.19 | Plasmodium falciparum | 4m1n_b | Q8I301 | 99.90 | 1.80E-33 | 1.20E-37 | 175.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |